Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome. | Nat Struct Mol Biol | 2022 | 36175670 | PubTator, text mining | PubMed |
| Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor. | Science | 2022 | 36173843 | PubTator, text mining | PubMed |
| Ultrasonographic analysis of Langerhans cell histiocytosis in children: a report of 55 cases. | J Int Med Res | 2022 | 36168708 | PubTator, text mining | PubMed |
| Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases. | Case Rep Endocrinol | 2022 | 36160179 | PubTator, text mining | PubMed |
| New methodology of TMB assessment from tissue and liquid biopsy in NSCLC. | PLoS One | 2022 | 36155654 | PubTator, text mining | PubMed |
| Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors. | Nat Commun | 2022 | 36153311 | PubTator, text mining | PubMed |
| A novel 16-gene alternative mRNA splicing signature predicts tumor relapse and indicates immune activity in stage I-III hepatocellular carcinoma. | Front Pharmacol | 2022 | 36147313 | PubTator, text mining | PubMed |
| TTYH3 Modulates Bladder Cancer Proliferation and Metastasis via FGFR1/H-Ras/A-Raf/MEK/ERK Pathway. | Int J Mol Sci | 2022 | 36142409 | PubTator, text mining | PubMed |
| Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds. | Sci Rep | 2022 | 36138080 | PubTator, text mining | PubMed |
| Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance. | Front Oncol | 2022 | 36119516 | PubTator, text mining | PubMed |
| KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment of Pancreatic Cancer. | J Cancer | 2022 | 36118526 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers. | J Clin Med | 2022 | 36079062 | PubTator, text mining | PubMed |
| Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations. | Cancers (Basel) | 2022 | 36077815 | PubTator, text mining | PubMed |
| BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors. | Cancers (Basel) | 2022 | 36077798 | PubTator, text mining | PubMed |
| BRAF Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies. | Cancers (Basel) | 2022 | 36077604 | PubTator, text mining | PubMed |
| Mechanism and inhibition of BRAF kinase. | Curr Opin Chem Biol | 2022 | 36067564 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer. | Front Cell Dev Biol | 2022 | 36060798 | PubTator, text mining | PubMed |
| Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review. | Front Oncol | 2022 | 36059688 | PubTator, text mining | PubMed |
| Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma. | Life Sci Alliance | 2022 | 36038253 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=20